𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adult and infantile Gaucher disease in one family: Mutational studies and clinical update

✍ Scribed by Maryam Shahinfar; David A. Wenger

Book ID
117163325
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
741 KB
Volume
125
Category
Article
ISSN
1097-6833

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Infantile Pompe disease on ERTβ€”Update on
Infantile Pompe disease on ERTβ€”Update on clinical presentation, musculoskeletal management, and exercise considerations
✍ Laura E. Case; Alexandra A. Beckemeyer; Priya S. Kishnani πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 393 KB

## Abstract Enzyme replacement therapy (ERT) with alglucosidase alpha, approved by the FDA in 2006, has expanded possibilities for individuals with Pompe disease (glycogen storage disease type II, GSDII, or acid maltase deficiency). Children with infantile Pompe disease are surviving beyond infancy

Two new mild homozygous mutations in Gau
Two new mild homozygous mutations in Gaucher disease patients: Clinical signs and biochemical analyses
✍ Cormand, Bru; Grinberg, Daniel; Gort, Laura; Fiumara, Agata; Barone, Rita; Vilag πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 324 KB

Gaucher disease (GD) is a lysosomal storage disorder resulting from impaired activity of lysosomal ␀-glucocerebrosidase. More than 60 mutations have been described in the GBA gene. They have been classified as lethal, severe, and mild on the basis of the corresponding phenotype. The fact that most G